EXOME: Biotech • Healthcare • Life Sciences

Boston
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic

Learn about the Xconomists →

Bryony Winn

Bryony Winn

Chief Strategy and Innovation Officer, Blue Cross and Blue Shield of North Carolina

Digital Health Survivors & Innovative Incumbents Must Team Up for True Disruption

Rob Coppedge

Rob Coppedge

CEO of Echo Health Ventures

Partner or Die: How to Succeed Even After the Digital Health Hype Quiets Down

More Opinion, Insight, and Analysis ›

Xcelerating Life Sciences Boston

April 29, 2020

$201M

Black Diamond Therapeutics

Shattuck Labs Promotes Schreiber to CEO, Succeeding Hornblower

Adaptimmune Taps Abcam’s Gavin Wood for Chief Financial Officer Role

Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
Frank Vinluan | San Francisco
Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential
Frank Vinluan | San Diego
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
Dan Stanton | National
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened.
Frank Vinluan | National
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts
Frank Vinluan | Boston
Wave Life Sciences’ Stumble in Duchenne Leads to 22% Staff Layoff
Frank Vinluan | Boston
Biohaven Drug Fails Anxiety Study, Data in OCD and More Still to Come
Frank Vinluan | New York
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s
Frank Vinluan | National
Bio Roundup: POTUS on Prices, a16z’s Fund, Aimmune’s Approval & More
Sarah de Crescenzo | National

Read More Posts ›

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Sponsored · Whitepaper
Time Savings That Speed up Science
Monitor spending and save meaningful dollars with life sciences-specific rewards
Brex

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!